About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cd36tm1Frm
targeted mutation 1, Mason W Freeman
MGI:2447190
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Cd36tm1Frm/Cd36tm1Frm B6.129S4-Cd36tm1Frm MGI:4452600
hm2
Cd36tm1Frm/Cd36tm1Frm involves: 129S4/SvJae MGI:3815303
hm3
Cd36tm1Frm/Cd36tm1Frm involves: 129S4/SvJae * C57BL/6J MGI:3815318


Genotype
MGI:4452600
hm1
Allelic
Composition
Cd36tm1Frm/Cd36tm1Frm
Genetic
Background
B6.129S4-Cd36tm1Frm
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd36tm1Frm mutation (0 available); any Cd36 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• intravenous infection with encapsulated S. aureus, Reynolds strain, results in 20% death by 6-8 days compared to 0% death in similarly infected wild-type mice
• 50% of mice infected intravenously with unencapsulated S. aureus, strain 3825-4, succumb to infection compared to 0% death in similarly infected wild-type mice

immune system
• show a 40-50% reduction in phagocytosis of S.aureus
• comparable levels of internalization of E. coli relative to wild-type
• 60% reduction in the ability to internalize lipoteichoic acid
• macrophages treated with S. aureus for 4 hours show a 65-75% decrease in IL-12 secretion as compared with wild-type macrophage
• macrophages treated with lipoteichoic acid demonstrate a 60-70% decrease in IL-12 secretion
• macrophages treated with E.coli show a 25% decrease in the secretion of IL-6
• macrophages treated with S. aureus for 4 hours show a 65-75% decrease in TNF alpha secretion as compared with wild-type macrophage
• macrophages treated with lipoteichoic acid demonstrate a 60-70% defect in TNF secretion
• macrophages treated with E.coli show a 25% decrease in the secretion of TNF alpha
• pericardial and perinephric abscess formation in mice infected intravenously with unencapsulated S. aureus
• perinephric abscess formation in 50% of mice infected intravenously with encapsulated S.aureus
• intravenous infection with encapsulated S. aureus, Reynolds strain, results in 20% death by 6-8 days compared to 0% death in similarly infected wild-type mice
• 50% of mice infected intravenously with unencapsulated S. aureus, strain 3825-4, succumb to infection compared to 0% death in similarly infected wild-type mice
• mice infected with encapsulated S. aureus, Reynolds strain, develop bacteraemia, resulting in a 3.8 x 10^9 S. aureus colony forming units per milliliter of blood on day

cardiovascular system
• 100% of the surviving mice infected intravenously with unencapsulated S. aureus strain 3825-4, develop perinephric and/or pericardial abscesses

renal/urinary system
• 50% of the animals infected intravenously with encapsulated S. aureus, Reynolds strain, have perinephric abscess formation whereas only 1 of 10 wild-type mice have an apparent abscess of the kidney
• 100% of the surviving mice infected intravenously with unencapsulated S. aureus strain 3825-4, develop perinephric and/or pericardial abscesses

hematopoietic system
• show a 40-50% reduction in phagocytosis of S.aureus
• comparable levels of internalization of E. coli relative to wild-type
• 60% reduction in the ability to internalize lipoteichoic acid

cellular
• show a 40-50% reduction in phagocytosis of S.aureus
• comparable levels of internalization of E. coli relative to wild-type
• 60% reduction in the ability to internalize lipoteichoic acid




Genotype
MGI:3815303
hm2
Allelic
Composition
Cd36tm1Frm/Cd36tm1Frm
Genetic
Background
involves: 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd36tm1Frm mutation (0 available); any Cd36 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• primary microglial cultures fail to exhibit activation following treatment with SNCA unlike wild-type cells and produce less cellular reactive oxygen species than similarly treated wild-type cells

nervous system
• primary microglial cultures fail to exhibit activation following treatment with SNCA unlike wild-type cells and produce less cellular reactive oxygen species than similarly treated wild-type cells

hematopoietic system
• primary microglial cultures fail to exhibit activation following treatment with SNCA unlike wild-type cells and produce less cellular reactive oxygen species than similarly treated wild-type cells




Genotype
MGI:3815318
hm3
Allelic
Composition
Cd36tm1Frm/Cd36tm1Frm
Genetic
Background
involves: 129S4/SvJae * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd36tm1Frm mutation (0 available); any Cd36 mutation (34 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• fibrillar beta-amyloid stimulated reactive oxygen species production is reduced 80% compared to in wild-type cells
• fibrillar beta-amyloid stimulated MCP-1 production in macrophages is reduced to 75% of wild-type

homeostasis/metabolism
• fibrillar beta-amyloid stimulated MCP-1 production in macrophages is reduced to 75% of wild-type

hematopoietic system
• fibrillar beta-amyloid stimulated reactive oxygen species production is reduced 80% compared to in wild-type cells





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory